myeloproliferative neoplasms mpns hematology crg page 1 myeloproliferative neoplasms mpns excluding cml primary myelofibrosis pmf stanford cancer center hematology crg 13 february 2012 click here to print this page pdf please mark up a copy using black ink and fax changes to 725 9204 intermediate & high risk aggressive systemic mastocytosis mast cell leukemia hemmpd0007 phase ii midostaurin for asm or mcl associated hematological clonal non mast cell lineage disease pi gotlib novartis hemmpd0013 phase ii ab0024 in primary post polycythemia vera or post essential thrombocythemia myelofibrosis pi gotlib gilead sciences hemmpd0011 investigation of dysregulated signaling in mpd via multiparameter phospho specific flow cytometry pi gotlib oh stanford 3rd priority pending optional path open for enrollment link trial posting observational study enrollment on hold key hemmpd0014 phase ii study ipi 926 in myelofibrosis pi gotlib infinity pharmaceuticals 1st priority hemmpd0015 phase iii sar302503 in primary post polycythemia vera post essential thrombocythemia myelofibrosis pi gotlib pending 2nd priority
